Will a company be discharged if it acts on valid nomination?

The Companies Act, 1956 has now recognized nomination. Brawn Pharmaceuticals Limited will be fully protected if it acts on the nomination. It is also necessary for Brawn Pharmaceuticals Limited to act on the nomination. The instruction given in the prescribed nomination form states that transfer of shares / debentures in favour of the nominee and repayment of the amount of deposits to the nominee shall be a valid discharge by a company against the legal heir.

Once a nomination is made, the same will qua Brawn Pharmaceuticals Limited, override all claims from the legal heirs under the succession certificate or from beneficiaries/executors under a Will executed by the deceased shareholder.

By BrawnBiotech|2017-01-30T15:30:08+05:30January 30th, 2017|Comments Off

About the Author: BrawnBiotech

IMPORTANT ANNOUNCEMENT

To,

The Shareholders/ Promoters,

Pursuant to SEBI Circular No. SEDI/HO/MIRSD-PoD/P/CIR/2025/97, dated July 02, 2025, the Company is pleased to offer one time special window for physical shareholders to submit re-lodgement requests for the transfer of shares. The Special Window will be open from July 07, 2025 to January 06, 2026 and is applicable to cases where original share transfer requests were lodged prior to April 01, 2019 and were returned/ unattended or rejected due to deficiencies in documentation, process or any other reason. The shares re-lodged for transfer will be processed only in dematerialized form during this window. Eligible shareholders may submit their transfer requests along with the requisite documents to the Company’s Registrar and Share Transfer Agent (RTA) at RCMC Share Registry Pvt. Ltd. , B-25/1, 1^st Floor, Okhla Industrial Area, Phase II, New Delhi, 110020, India.

UPDATE KYC AND CONVERT PHYSICAL SHARES INTO DEMAT MODE

The Shareholders who are holding shares in Physical form are requested to update their KYC and also requested to convert their physical share Certificates in to dematerialized form ( electronic Form).Further pursuant to SEBI Circular No. SEBI/Cir/ISD/3/2011 dated June 17, 2011 in order to promote dematerialization of securities, it is mandatory for the Company to achieve 100% of promoter’s and promoter group’s shareholding in dematerialized form, thereby they are requested to convert their holdings in dematerialized form on priority basis.

Thanks

Brawn Biotech Limited.

This will close in 0 seconds